查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566841

Ibuprofen市场：按类型、应用、分销管道分类：2024-2033 年全球机会分析与产业预测

Ibuprofen Market By Type , By Application By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格
简介目录

Ibuprofen市场

2023年Ibuprofen市值为1亿美元，预计2024年至2033年复合年增长率为7.9%，2033年达2.136亿美元。

Ibuprofen是非类固醇消炎剂，因其能够缓解疼痛、减轻发炎和退烧而广受欢迎。它属于镇痛药类别，用于缓解轻度至中度疼痛，如头痛、肌肉痛、牙痛、月经痛和关节炎。此药的作用机转是抑制体内琴酒的产生，前列腺素是一种引起疼痛和发炎的化合物。

Ibuprofen在治疗多种健康状况方面的多功能性是市场的关键驱动力。此外，Ibuprofen作为非处方药在某些国家的需求量很大，有助于自我治疗并增加客户的便利性。目前市场正出现一个新趋势：药品去石化。Ibuprofen的典型来源是原油。在最近的一项研究中，巴斯大学的研究人员发现了一种利用造纸工业产生的废弃物开发药物的方法。这项发现意味着製药业向永续性迈出了重要一步。

儘管具有功效，长期使用Ibuprofen会引起严重的副作用，包括心血管风险、胃肠道併发症和肾臟损伤。这些因素导致许多人不服药，从而限制了市场的成长。根据《英国医学杂誌》发表的一项研究，Ibuprofen预计会使心臟麻痹的风险增加 31%。同样，发表在《美国科学院院刊》上的一项研究发现，年轻健康男性服用高剂量的Ibuprofen会减少生殖激素的分泌，并导致补偿性腺功能减退症的发生。

按部门审查

Ibuprofen市场分为类型、应用、分销管道和区域。依类型划分，市场分为锭剂、胶囊、糖浆、注射等。依用途分为类风湿性关节炎/骨关节炎、癌症、疼痛/发烧/月经、发炎疾病、头痛等。根据分销管道，市场分为医院药房、零售药房和网路药房。从区域来看，分析涵盖北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

主要发现

按类型划分，锭剂细分市场将在 2023 年占据市场占有率。

从应用来看，类风湿性关节炎细分市场在 2023 年的收益最高。

从分销管道来看，医院药房业务在2023年获得了较高的市场占有率。

按地区划分，预计到 2033 年，北美将主导市场。

该报告可以定制。

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 扩大公司简介列表
  • 历史市场资料
  • 主要参与企业的详细资料（Excel格式，包括位置、联络资讯、供应商/供应商网路等）

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第 4 章Ibuprofen市场：按类型

  • 市场概况
  • 锭剂
  • 胶囊
  • 糖浆剂
  • 注射
  • 其他的

第五章Ibuprofen市场：依应用分类

  • 市场概况
  • 类风湿性关节炎和骨关节炎
  • 癌症
  • 疼痛/发烧/月经
  • 发炎疾病
  • 头痛
  • 其他的

第六章Ibuprofen市场：按分销管道

  • 市场概况
  • 医院药房
  • 零售药房
  • 网路药房

第七章Ibuprofen市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国Ibuprofen市场
    • 加拿大Ibuprofen市场
    • 墨西哥Ibuprofen市场
  • 欧洲
    • 主要市场趋势和机会
    • 德国Ibuprofen市场
    • 法国Ibuprofen市场
    • 英国Ibuprofen市场
    • 义大利Ibuprofen市场
    • 西班牙Ibuprofen市场
    • 其他欧洲Ibuprofen市场
  • 亚太地区
    • 主要市场趋势和机会
    • 日本Ibuprofen市场
    • 中国Ibuprofen市场
    • 澳洲Ibuprofen市场
    • 印度Ibuprofen市场
    • 韩国Ibuprofen市场
    • 其他亚太地区Ibuprofen市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • Ibuprofen市场
    • 沙乌地阿拉伯Ibuprofen市场
    • 南非Ibuprofen市场
    • 其他拉丁美洲/中东/非洲Ibuprofen市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • Pfizer Inc.
  • Abbott Laboratories
  • Solara Active Pharma Sciences Ltd
  • BASF SE
  • Biocause Inc
  • Shandong Xinhua Pharmaceutical Co Ltd
  • IOL Chemicals And Pharmaceutical Ltd
  • Hubei Biocause Pharmaceutical Co Ltd
  • Strides Pharma Science Ltd
  • Perrigo Company Plc
简介目录
Product Code: A65446

Ibuprofen Market

The ibuprofen market was valued at $100.0 million in 2023 and is projected to reach $213.6 million by 2033, growing at a CAGR of 7.9% from 2024 to 2033.

Ibuprofen is a nonsteroidal anti-inflammatory drug popular for its efficacy in alleviating pain, reducing inflammation, and lowering fever. It belongs to the analgesics class of medications which are used to ease mild to moderate pain, such as headaches, muscle aches, toothaches, menstrual cramps, and arthritis. The action mechanism of the medication involves inhibiting the production of prostaglandins inside the body, compounds that are the cause of pain and inflammation.

The versatility of ibuprofen in treating several health conditions is a key driver of the market. In addition, ibuprofen witnesses a high demand in several countries where it is accessible as over-the-counter medication, hence contributing to self-medication and elevating the convenience of customers. The market is currently witnessing an emerging trend of de-fossilization of pharmaceuticals. The typical source of formation of ibuprofen is from crude oils. Researchers at the University of Bath have recently discovered a method to develop the medication out of waste generated from the paper manufacturing industry. This discovery marks a significant step by the pharmaceuticals industry toward sustainability.

Despite its benefits, long-term usage of ibuprofen is known to cause severe side-effects such as cardiovascular risks, gastrointestinal complications, and kidney damage. These factors deter several individuals from the consumption of medication, hence restraining the market growth. According to a study posted by the British Medical Journal, ibuprofen is anticipated to elevate the risk of cardiac arrests by 31%. In a similar way, a study published in the Proceedings of the National Academy of Sciences states that high uptake of ibuprofen in young healthy men results in less production of reproductive hormones and occurrence of compensated hypogonadism disorder.

Segment Review

The ibuprofen market is segmented into type, application, distribution channel, and region. On the basis of type, the market is divided into tablet, capsule, syrup, injection, and others. As per application, it is classified into rheumatoid arthritis & osteoarthritis, cancer, pain/fever/dysmenorrhea, inflammatory diseases, headache, and others. Depending on distribution channel, the market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the tablet segment dominated the market share in 2023.

As per application, the rheumatoid arthritis segment generated the highest revenue in 2023.

Depending on distribution channel, the hospital pharmacies segment acquired a high market share in 2023.

Region wise, North America is expected to dominate the market by 2033.

Competition Analysis

The major players operating in the global ibuprofen market include Pfizer Inc., Abbott Laboratories Ltd., Solara Active Pharma Sciences Ltd., ?h?nd?ng ??nhu? ?h?rm???ut???l ??.Ltd, ??L ?h?m???l? and ?h?rm???ut???l L?m?t?d, ?ub?? ?????u?? ?h?rm???ut???l ??.Ltd, ?tr?d?? ?h?rm? ????n?? L?m?t?d (?h??un ?h?rm???ut???l? L?m?t?d), ??rr?g? ??m??n? ?l?, BASF SE, and Biocause Inc. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Type

  • Tablet
  • Capsule
  • Syrup
  • Injection
  • Others

By Application

  • Rheumatoid Arthritis and Osteoarthritis
  • Cancer
  • Pain/Fever/Dysmenorrhea
  • Inflammatory Diseases
  • Headache
  • Others

By Distribution Channel

  • Hospital pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Pfizer Inc.
    • Abbott Laboratories
    • Solara Active Pharma Sciences Ltd
    • BASF SE
    • Biocause Inc
    • Shandong Xinhua Pharmaceutical Co Ltd
    • IOL Chemicals and Pharmaceutical Ltd
    • Hubei Biocause Pharmaceutical Co Ltd
    • Strides Pharma Science Ltd
    • Perrigo Company Plc

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: IBUPROFEN MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Tablet
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Capsule
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Syrup
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Injection
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. Others
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: IBUPROFEN MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Rheumatoid Arthritis And Osteoarthritis
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Cancer
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Pain/Fever/Dysmenorrhea
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Inflammatory Diseases
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Headache
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country
  • 5.7. Others
    • 5.7.1. Key Market Trends, Growth Factors and Opportunities
    • 5.7.2. Market Size and Forecast, By Region
    • 5.7.3. Market Share Analysis, By Country

CHAPTER 6: IBUPROFEN MARKET, BY DISTRIBUTION CHANNEL

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Distribution Channel
  • 6.2. Hospital Pharmacies
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Retail Pharmacies
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Online Pharmacies
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: IBUPROFEN MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By Distribution Channel
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Ibuprofen Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By Distribution Channel
    • 7.2.7. Canada Ibuprofen Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By Distribution Channel
    • 7.2.8. Mexico Ibuprofen Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By Distribution Channel
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By Distribution Channel
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Ibuprofen Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By Distribution Channel
    • 7.3.7. France Ibuprofen Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By Distribution Channel
    • 7.3.8. UK Ibuprofen Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By Distribution Channel
    • 7.3.9. Italy Ibuprofen Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By Distribution Channel
    • 7.3.10. Spain Ibuprofen Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By Distribution Channel
    • 7.3.11. Rest of Europe Ibuprofen Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By Distribution Channel
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By Distribution Channel
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Ibuprofen Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By Distribution Channel
    • 7.4.7. China Ibuprofen Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By Distribution Channel
    • 7.4.8. Australia Ibuprofen Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By Distribution Channel
    • 7.4.9. India Ibuprofen Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By Distribution Channel
    • 7.4.10. South Korea Ibuprofen Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By Distribution Channel
    • 7.4.11. Rest of Asia-Pacific Ibuprofen Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By Distribution Channel
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By Distribution Channel
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Ibuprofen Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By Distribution Channel
    • 7.5.7. Saudi Arabia Ibuprofen Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By Distribution Channel
    • 7.5.8. South Africa Ibuprofen Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By Distribution Channel
    • 7.5.9. Rest of LAMEA Ibuprofen Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By Distribution Channel

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Pfizer Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Abbott Laboratories
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Solara Active Pharma Sciences Ltd
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. BASF SE
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Biocause Inc
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Shandong Xinhua Pharmaceutical Co Ltd
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. IOL Chemicals And Pharmaceutical Ltd
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Hubei Biocause Pharmaceutical Co Ltd
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Strides Pharma Science Ltd
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Perrigo Company Plc
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments